Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT).
Pao M, Papadopoulos EB, Chou J, Glenn H, Castro-Malaspina H, Jakubowski AA, Kernan NA, Perales MA, Prokop S, Scaradavou A, vanDenBrink MR, Young JW, O'Reilly RJ, Small TN. Pao M, et al. Among authors: chou j. Biol Blood Marrow Transplant. 2008 Sep;14(9):1022-1030. doi: 10.1016/j.bbmt.2008.06.012. Biol Blood Marrow Transplant. 2008. PMID: 18721765 Free PMC article.
Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT).
Chou JF, Kernan NA, Prockop S, Heller G, Scaradavou A, Kobos R, Knowles MA, Papadopoulos EB, Casson A, Copeland C, Torok-Castanza J, Zakak N, Ruggiero J, Small TN. Chou JF, et al. Biol Blood Marrow Transplant. 2011 Nov;17(11):1708-13. doi: 10.1016/j.bbmt.2011.05.006. Epub 2011 May 23. Biol Blood Marrow Transplant. 2011. PMID: 21664979 Free PMC article.
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.
Goldberg JD, Chou JF, Horwitz S, Teruya-Feldstein J, Barker JN, Boulad F, Castro-Malaspina H, Giralt S, Jakubowski AA, Koehne G, van den Brink MRM, Young JW, Zhang Z, Papadopoulos EB, Perales MA. Goldberg JD, et al. Among authors: chou jf. Leuk Lymphoma. 2012 Jun;53(6):1124-1129. doi: 10.3109/10428194.2011.645818. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22136377 Free PMC article.
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation.
Doubrovina E, Oflaz-Sozmen B, Prockop SE, Kernan NA, Abramson S, Teruya-Feldstein J, Hedvat C, Chou JF, Heller G, Barker JN, Boulad F, Castro-Malaspina H, George D, Jakubowski A, Koehne G, Papadopoulos EB, Scaradavou A, Small TN, Khalaf R, Young JW, O'Reilly RJ. Doubrovina E, et al. Among authors: chou jf. Blood. 2012 Mar 15;119(11):2644-56. doi: 10.1182/blood-2011-08-371971. Epub 2011 Dec 2. Blood. 2012. PMID: 22138512 Free PMC article.
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies.
Sauter CS, Chou JF, Papadopoulos EB, Perales MA, Jakubowski AA, Young JW, Scordo M, Giralt S, Castro-Malaspina H. Sauter CS, et al. Leuk Lymphoma. 2014 Dec;55(12):2739-47. doi: 10.3109/10428194.2014.894185. Epub 2014 Mar 20. Leuk Lymphoma. 2014. PMID: 24528216 Free PMC article. Clinical Trial.
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD, Zhou P, Chou J, Teruya-Feldstein J, Reich L, Hassoun H, Levine B, Filippa DA, Riedel E, Kewalramani T, Stubblefield MD, Fleisher M, Nimer S, Comenzo RL. Cohen AD, et al. Among authors: chou j. Br J Haematol. 2007 Oct;139(2):224-33. doi: 10.1111/j.1365-2141.2007.06783.x. Br J Haematol. 2007. PMID: 17897298 Free article. Clinical Trial.
2,516 results